OGN - CIK 0001821825
Organon & Co. (OGN) reported revenue of $6.22B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $6.22B | -2.9% |
| FY 2024 | $6.40B | +2.2% |
| FY 2023 | $6.26B | +1.4% |
| FY 2022 | $6.17B | -2.1% |
| FY 2021 | $6.30B | -3.5% |
| FY 2020 | $6.53B | -16.0% |
| FY 2019 | $7.78B | - |
Organon & Co. (OGN) reported revenue of $6.22B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, Organon & Co.'s revenue declined from $7.78B to $6.22B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.